| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Johnson & Johnson is experiencing a notable surge in their product development initiatives, with a strong emphasis on innovative solutions such as Spravato and advancements in AI and robotics. The company's latest drug launches are achieving remarkable success, significantly outperforming previous products and leading to a positive market reception. The combination of effective product innovation and a robust pipeline bodes well for future growth. However, the competitive landscape may pose challenges as rivals attempt to catch up. |
| The price action of JOHNSON & JOHNSON (JNJ) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -0.8 is bearish. The market sentiment at 1 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for JNJ since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 1.2, and the negative at -0.2 on 2026-07-15. The forces of Stock Price Trend (-0.8), and Sector Price Trend (-0.4) will drive down the price. The forces of Price Level Sentiment (0), Market Risk Appetite (0.6), Option Sentiment (1.5), Valuation Sentiment (1.7), and Sentiment towards Fundamentals (3.2) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| JNJ | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-15 | 1%(0.1%) | 247 | 4.61% | 43 | 55 | 25 | -2.7% | -0.27% | -0.8 | -0.9 | 1.3% | 1 | Short | 55% | 3.2 | 5 |
| 2026-07-14 | 0%(0%) | 253.86 | 4.64% | 59 | 62 | 38 | -1.59% | -0.15% | -0.4 | -0.2 | 0.8% | 1.1 | Short | 55% | 2.3 | 6.7 |
| 2026-07-13 | 0%(0%) | 257.97 | 4.61% | 69 | 71 | 46 | 0.37% | 0.12% | 0.5 | 0 | 0.4% | 0.5 | Long | 55% | 1.1 | -1 |
| 2026-07-12 | 0%(0%) | 0.7 | 0 | 0.6 | 1.3 | -1 | ||||||||||
| 2026-07-11 | 0%(0%) | 0.7 | 0 | 0.8 | 2.1 | -1 | ||||||||||
| 2026-07-10 | 0%(0%) | 257.03 | 4.64% | 69 | 72 | 22 | -0.8% | 0.47% | 0.7 | -0.4 | 1.2% | 0.7 | Wait | 50% | 1.2 | -1 |
| 2026-07-09 | 0%(0%) | 259.1 | 4.59% | 75 | 68 | 13 | -1.61% | 0.7% | 1.4 | -0.5 | 1.2% | 0.6 | Wait | 50% | 1.4 | -1 |
| 2026-07-08 | 0%(0%) | 263.35 | 4.46% | 87 | 71 | 23 | -1.48% | 0.99% | 2.1 | -0.3 | 1.2% | 0.7 | Long | 65% | 1.9 | -1 |
| 2026-07-07 | 0%(0%) | 267.3 | 4.26% | 100 | 75 | 79 | 3.07% | 1.44% | 2.5 | 0.4 | 1.5% | 1.3 | Long | 70% | 2 | -1 |
| 2026-07-06 | 0%(0%) | 259.34 | 3.99% | 90 | 65 | 29 | -1.41% | 1.26% | 2.1 | -0.1 | 0.8% | 1.4 | Wait | 50% | 2.6 | 6 |
| Short is the preferred trading strategy with 55% chance of being right. Weak trend sentiment and negative hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| 2026-07-15 17:47:53 Analysts are adjusting their price targets based on the company's positive outlook despite mixed quarterly results. |
| 2026-07-15 17:47:53 Johnson & Johnson's latest drug launch is noted for its exceptional performance in the market. |
| 2026-07-15 17:47:53 The positive earnings results and optimistic outlook for the full year suggest healthy company performance. |
| 2026-07-15 17:47:53 The articles highlight the strong performance of Johnson & Johnson's stock and its potential to reach new highs. |
| 2026-07-15 17:02:33 Johnson & Johnson's status as a Dividend King and strong portfolio make it an attractive long-term investment option. |
| 2026-07-15 17:02:33 The stock price has experienced fluctuations, including recent dips despite positive earnings, causing concern among investors. |
| 2026-07-15 17:02:33 Despite some challenges, the company raises its full-year outlook, reflecting optimism about future growth. |
| 2026-07-15 17:02:33 The company continues to innovate, particularly with its Spravato treatment and advancements in AI and robotics for medical applications. |
| 2026-07-15 17:02:33 Johnson & Johnson shows consistent earnings performance, beating expectations in recent quarters, which boosts investor confidence. |
| 2026-07-15 15:48:39 The company has raised its full-year outlook, illustrating confidence in sustained growth and management's positive leadership. |
| 2026-07-15 15:48:39 The mentioned drug is reportedly outperforming most recent launches, suggesting successful product development and market reception. |
| 2026-07-15 15:48:39 The article highlights Johnson & Johnson's earnings that beat expectations, indicating strong financial performance. |
| 2026-07-15 13:48:59 The raising of the full-year outlook suggests confidence from company leadership in future financial performance. |
| 2026-07-15 13:48:59 The article emphasizes a specific drug from Johnson & Johnson that is outperforming other recent product launches, indicating significant success in product development. |
| 2026-07-15 13:48:59 The article highlights Johnson & Johnson's earnings that narrowly beat expectations, reflecting strong financial performance. |
| 2026-07-15 09:35:51 The strong performance of J&J’s immunology drug Tremfya and cancer treatments reflects a positive trend in pharmaceutical sales. |
| 2026-07-15 09:35:51 Despite strong drug sales, the articles report disappointing demand for J&J's medical devices, impacting overall stock performance. |
| 2026-07-15 09:35:51 The articles highlight Johnson & Johnson's strong quarterly earnings, surpassing Wall Street estimates and increasing profit forecasts. |